Online Database of Chemicals from Around the World Search | Submit | Advertise

Home >> Chemical Listing >> Fevipiprant>> Market Analysis Reports
 

Market Analysis Reports of Fevipiprant

Targeted Therapies in Asthma: KOL Insight [2018]
... about. Is it AstraZeneca/Amgen’s tezepelumab? Novartis’ fevipiprant? Or something else? Read the report ... -Registered Therapies Benralizumab (anti-IL-5; AstraZeneca) Fevipiprant (anti-CRTh2; Novartis) Tralokinumab (anti ...

Prostaglandin D2 receptor Antagonist - Pipeline Insight, 2022
... Key Products CSPCHA-115 Asapiprant Fevipiprant Timapiprant ACT-774312 SLS 008 ...

Atopic Dermatitis [2017]
... (P1/P2) Tezepelumab (anti-TSLP; Amgen/AstraZeneca) Fevipiprant (CRTH2 antagonist; Novartis) GR MD 02 (Galectin 3 inhibitor ...

Asthma: Disease Inights and Market Forecasts to 2024
Delivery time for this report is 5 days “Asthma: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Asthma disease in the US, EU5 (Germany, France, Italy, Spain ...

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2018
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2018 SUMMARY Prostaglandin D2 Receptor 2 (Chemoattractant Receptor ...

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018 SUMMARY Prostaglandin D2 Receptor 2 (Chemoattractant Receptor ...

Asthma: Pipeline Assessment and Insights
Delivery time for this report is 2-3 days “Asthma: Pipeline Assessment and Insights” report delivers an in-depth understanding of the disease, highlights all the pipeline products in different phases of development for the disease including the Suspended ...

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020, provides an overview of the Nasal Polyps (Nasal ...

Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019
Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019 SUMMARY Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) ...

Nasal Polyps - Pipeline Review, H2 2019
Nasal Polyps - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H2 2019, provides an overview of the Nasal Polyps (Ear Nose Throat Disorders) pipeline ...

Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019
Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019'; Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 ...

Nasal Polyposis - Pipeline Insight, 2021
... Products Benralizumab AK001 ACT-774312 Fevipiprant

Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021
Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In ...

Nasal Polyps (Nasal Polyposis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Nasal Polyps (Nasal Polyposis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal Polyposis) - Drugs ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact